#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    C3 glomerulopathy Focal segmental glomerulosclerosis Idiopathic pulmonary fibrosis Astrocytoma Pneumonia Postprandial hypoglycaemia Turner's syndrome Antisynthetase syndrome Encephalopathy neonatal Retinopathy of prematurity Henoch-Schonlein purpura nephritis Alternating hemiplegia of childhood Synovial sarcoma metastatic Acromegaly Chronic graft versus host disease in skin More trials…

    Learn about Rare Diseases

    Angiosarcoma Mucopolysaccharidosis III – Life with Disease Primary biliary cholangitis – Life with Disease Friedreich’s ataxia Carcinoid syndrome Sarcoidosis – Basic Information Lymphangiosarcoma – Treatment Medulloblastoma recurrent – Trials in Disease Marginal zone lymphoma refractory – Trials in Disease Carcinoid syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lactose Monohydrate Triamcinolone Olaparib Leuprorelin Acetate Mk-6194 Nimodipine Mavacamten Nitrous Oxide Gozetotide Alf-18 Remibrutinib Myrrh Deflazacort Leuprorelin Chlorphenamine Maleate Pf-06480605 Phleum Pratense Pollen Extract Peginterferon Beta-1A Perflutren Nvl-655 Cefaclor More therapies…

    Learn about Your Condition

    Myelodysplastic syndrome Cardiac disorder Progressive multiple sclerosis Body mass index increased Melanoma recurrent Cervix carcinoma stage I Transplantation complication Meniere's disease Vasospasm Phaeochromocytoma Hepatorenal syndrome Hairy cell leukaemia Muscle strain Breast cancer stage I Amnestic disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • A Study of OVX836 Influenza Vaccine Given as Booster or Primary Vaccination in Healthy Adults Who Previously Received OVX836, Influenza Vaccine, or Placebo

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • INFLUENZA A (H1N1/WSN/1933) NUCLEOPROTEIN FUSED TO C-TERMINAL FRAGMENTS OF TWO AVIAN C4BP ALFA CHAIN SEQUENCES
    Belgium

  • Study on the Best Time for Influenza Vaccine Administration in Adults Aged 60-85 Using Influenza Vaccine and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 17F
    • Pneumococcal Polysaccharide Serotype 2
    • Pneumococcal Polysaccharide Serotype 20
    The Netherlands

  • Study on the Immune Response to Bretovameran COVID-19 mRNA Vaccine in Healthy Adults Aged 18-40

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • COVID-19
    Belgium

  • Study of HSV immunotherapy (HSVTI) for healthy adults aged 18-40 and people with recurrent genital herpes aged 18-60

    Not recruiting

    2 1
    Investigated Diseases:
    • Herpes simplex
    Investigated Drugs:
    • GSKVX000000030810
    • GSKVX000000030825
    • GSKVX000000030918
    Belgium Estonia Germany Spain

  • Study Comparing High-Dose vs. Standard-Dose Influenza Vaccine for Preventing Flu in Older Adults

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224)
    • B/Washington/02/2019 – Like Virus (B/Washington/02/2019, Wild Type)
    • Elasomeran
    Denmark

  • Study on Lenacapavir for HIV Prevention in Individuals at Risk of HIV Infection

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Tenofovir Disoproxil Fumarate
    • Emtricitabine
    • Lenacapavir
    France
Previous Page
1 … 28 29 30 31 32 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!